Patients with brain metastases from gastrointestinal cancers show worse survival after stereotactic radiosurgery than those ...

Scientists uncover surprising immune response that helps tumors grow, revealing new strategies to improve treatment ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

Researchers have developed a lung-targeted nanoparticle delivery system for genetic therapies. In a major step forward for ...

Noelle Franklin was diagnosed with Osteosarcoma, a rare form of bone cancer, in May 2024. She passed away in May of this year.

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...

Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell ...

Small-cell lung cancer (SCLC) is one of the most lethal cancers, with patients diagnosed with extensive-stage small-cell lung cancer (ES-SCLC) experiencing a median survival of just 12 months after ...

The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...

Three years ago, before I learned that I had metastatic cancer, doctors repeatedly told me I was “too young” to be seriously ...